Discover 4,544 paid clinical trials in New York State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New York State presents a wide array of paid research opportunities for both healthy volunteers and those with specific health concerns. Actively recruiting research institutions in New York City, Buffalo, and Rochester offer access to innovative treatments and exceptional medical care near you.
Filter
1
Filter results
Results: 4,544
Active & Responsive
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
for
Alpha1-Antitrypsin Deficiency
Location: Halifax, Boston MA, New York NY, Philadelphia PA,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT05677971
Phase3, Recruiting
Active & Responsive
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma
for
Melanoma, Unresectable Melanoma
Location: Boston MA, New York NY, Los Angeles CA
Sponsor: NYU Langone Health
Sex: All
Age: 18 - 70+
Code: NCT05428007
Phase2, Recruiting
Active & Responsive
ME/CFS: Activity Patterns and Autonomic Dysfunction
for
Chronic Fatigue Syndrome
Location: Stony Brook NY
Sponsor: Stony Brook University
Sex: All
Age: 18 - 65
Code: NCT02948556
Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Augusta ME, Boston MA, Providence RI, Concord NH,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes
for
Diabetes Mellitus, Type 1, Diabetes Complications
Location: Boston MA, The Bronx NY
Sponsor: Boston Medical Center
Sex: All
Age: 18 - 70+
Code: NCT06236607
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Location: Mineola NY, New York NY, Montreal, Ottawa,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06428409
Phase1, Phase2, Recruiting
Active & Responsive
A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering
for
Scoliosis Idiopathic
Location: New York NY, Philadelphia PA, Washington DC, Ottawa,
Sponsor: Pediatric Spine Foundation
Sex: All
Age: 0 - 18
Code: NCT04914507
Recruiting
Active & Responsive
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer
Location: New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT05723107
Phase1, Recruiting
Active & Responsive
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
for
Extensive Stage-small Cell Lung Cancer
Location: Lebanon NH, Mineola NY, New York NY, Hackensack NJ,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06362252
Phase1, Phase2, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Boston MA, New Haven CT, West Haven CT, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase3, Recruiting
Active & Responsive
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.
for
Pressure Ulcer, Stage IV, Osteomyelitis
Location: Mineola NY, Newark NJ, Pittsburgh PA, Detroit MI,
Sponsor: Biocomposites Ltd
Sex: All
Age: 18+
Code: NCT06283979
Phase2, Recruiting
Active & Responsive
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
for
Prostate Cancer
Location: New York NY
Sponsor: NYU Langone Health
Sex: Male
Age: 18+
Code: NCT06397703
Phase2, Recruiting
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase2, Recruiting
Active & Responsive
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
for
Eosinophilic Gastrointestinal Disorders (EGIDs),
Location: New York NY, Philadelphia PA, Bethesda MD,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 3+
Code: NCT02523118
Recruiting
Active & Responsive
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies